K240558 is an FDA 510(k) clearance for the NAVOYCDS. This device is classified as a Multivariate Vital Signs Index (Class II - Special Controls, product code PLB).
Submitted by Algodx AB (Stockholm, SE). The FDA issued a Cleared decision on July 22, 2024, 145 days after receiving the submission on February 28, 2024.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2300. Automated Calculation Of A Summary Index (or Indices) Based On Several Individual Measured Vital Sign Inputs..